AMGN

2024Q1AMC

Amgen Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-05-02 · Fiscal end 2024-03-31 · Features as of 2024-05-02

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS3.89
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.1%
IV front—
P/C full—
P/C front—
Features as of2024-05-02

Run-up

Close—
Ret 5d+3.3%
Ret 10d+6.0%
Ret 20d+3.8%
Ret 30d+2.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
3.96Beat
Estimated EPS3.89
Actual revenue
7.4B
Surprise %+1.8%
Beat / missBeat
Beat streak 44
Beat streak 85

Reaction

1-day stock reaction-0.7%
Implied vs actual

Implied 2.1%Actual 12.6%

Gap reaction+12.6%
Day result+11.8%
Next-day upNo
Realized / IV5.93×

Post tape

Post 5d-0.4%
Post 10d+0.4%
Post volume9.6M
Vol ×10d3.80×
Vol ×20d4.23×
Post range4.4%